By offering unique services & products, Beximco, one of the largest conglomerates in Bangladesh, turned the outbreak into an opportunity. The first company to produce generic remdesivir, also supplied the US agencies with 6.5 million PPE masks & gowns.
The coronavirus pandemic has impacted the global economy in unprecedented ways –disruption in the supply chain, employee layoffs, and a decline in manufacturing – which have been the source of anxiety across the world. As per IMF, many now fear the disappearance of well-paying jobs for low & middle-skilled workers and ultimately worsening inequality.
With the outbreak continuing its dominance, the orders have been sent plummeting for most manufacturers in Bangladesh, like their peers elsewhere. However, Beximco Group, instead of succumbing to the worldwide pressure has turned this gloom into a bloom –churning out the most effective products to fight against COVID-19.
Co-owned by Salman F Rahman, one of the most successful businessmen in Bangladesh, Beximco Group was the first company to globally start producing and exporting a generic version of remdesivir by Gilead Sciences, as the treatment for COVID-19. So far, Beximco Pharma has sold around 25 K generic copies in Nigeria, Azerbaijan, the Philippines, among others.
Rabbur Reza, chief operating officer of Beximco Pharmaceuticals Ltd, said, “We are presently capable of producing 80,000 vials of Bemsivir per month.”
However, it is not just the pharmaceutical division which spearheaded delivery of unique products amidst the pandemic. Not too long ago, Beximco’s textile and apparel unit exported 6.5 million PPE gowns to the US Federal Emergency Management Agency.
About Beximco Group: The group, founded by brothers Salman Fazlur Rahman and Ahmed Sohail Fasihur Rahman, although began as a commodity trading house in the 1970s, now offers services in multiple sectors including energy, banking, IT, real estate, and media. Currently, Salman F Rahman, one of its co-founder, also serves as Prime Minister Sheikh Hasina’s private industry and investment adviser.